These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1362159

  • 1. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL.
    Eur J Pharmacol; 1992 Nov 13; 223(1):65-74. PubMed ID: 1362159
    [Abstract] [Full Text] [Related]

  • 2. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Sullivan CK, Fadayel GM.
    J Neurochem; 1994 Apr 13; 62(4):1382-9. PubMed ID: 7907650
    [Abstract] [Full Text] [Related]

  • 3. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM.
    Eur J Pharmacol; 1992 Sep 22; 220(2-3):151-9. PubMed ID: 1425989
    [Abstract] [Full Text] [Related]

  • 4. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR.
    J Pharmacol Exp Ther; 1991 Jan 22; 256(1):230-5. PubMed ID: 1899117
    [Abstract] [Full Text] [Related]

  • 5. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ.
    Neuropsychopharmacology; 1996 Aug 22; 15(2):116-24. PubMed ID: 8840347
    [Abstract] [Full Text] [Related]

  • 6. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Brain Res; 1990 Oct 08; 529(1-2):85-90. PubMed ID: 1980848
    [Abstract] [Full Text] [Related]

  • 7. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov 08; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 8. The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.
    Schmidt CJ, Fadayel GM.
    Eur J Pharmacol; 1995 Feb 06; 273(3):273-9. PubMed ID: 7737334
    [Abstract] [Full Text] [Related]

  • 9. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
    Nash JF.
    Life Sci; 1990 Feb 06; 47(26):2401-8. PubMed ID: 1979830
    [Abstract] [Full Text] [Related]

  • 10. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR.
    Br J Pharmacol; 2002 Jan 06; 135(1):170-80. PubMed ID: 11786492
    [Abstract] [Full Text] [Related]

  • 11. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors.
    Millan MJ, Colpaert FC.
    Eur J Pharmacol; 1991 Feb 07; 193(2):145-52. PubMed ID: 1675609
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.
    Sorensen SM, Kehne JH, Fadayel GM, Humphreys TM, Ketteler HJ, Sullivan CK, Taylor VL, Schmidt CJ.
    J Pharmacol Exp Ther; 1993 Aug 07; 266(2):684-91. PubMed ID: 8102646
    [Abstract] [Full Text] [Related]

  • 13. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.
    Hiramatsu M, DiStefano E, Chang AS, Cho AK.
    Eur J Pharmacol; 1991 Nov 05; 204(2):135-40. PubMed ID: 1725282
    [Abstract] [Full Text] [Related]

  • 14. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

  • 15. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    Huang X, Nichols DE.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):291-6. PubMed ID: 8104811
    [Abstract] [Full Text] [Related]

  • 16. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA, McCloskey TC, Kehne JH.
    Psychopharmacology (Berl); 1996 Mar 20; 124(1-2):107-16. PubMed ID: 8935805
    [Abstract] [Full Text] [Related]

  • 17. Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions.
    Lin HQ, McGregor IS, Atrens DM, Christie MJ, Jackson DM.
    Pharmacol Biochem Behav; 1994 Feb 20; 47(2):369-74. PubMed ID: 7908448
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct 20; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 19. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT, Champney TH, Frye GD.
    Pharmacol Biochem Behav; 1989 Aug 20; 33(4):741-7. PubMed ID: 2575758
    [Abstract] [Full Text] [Related]

  • 20. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP, Huang XM, Nichols DE.
    Pharmacol Biochem Behav; 1991 Dec 20; 40(4):915-22. PubMed ID: 1726189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.